Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Vemurafenib and ipilimumab for metastatic melanoma

Dr Caroline Robert - Institute Gustave Roussy, Paris, France

Vemurafenib and ipilimumab for metastatic melanoma ( Dr Caroline Robert - Institute Gustave Roussy, Paris, France )

Science behind phase I clinical trials: targeting tumour cell development...

Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA

Science behind phase I clinical trials: targeting tumour cell development pathways ( Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA )

Next generation of anti-cancer agents: data from ASCO 2013

Dr Sarah Blagden - Imperial College, London, UK

Next generation of anti-cancer agents: data from ASCO 2013 ( Dr Sarah Blagden - Imperial College, London, UK )

Phase I study measures effect of ipilimumab and nivolumab combination in...

Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA

Phase I study measures effect of ipilimumab and nivolumab combination in melanoma patients ( Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA )

Axillary radiotherapy provides alternative to invasive early stage breast...

Dr Emiel J. Rutgers - Netherlands Cancer Institute, Amsterdam

Axillary radiotherapy provides alternative to invasive early stage breast cancer surgery ( Dr Emiel J. Rutgers - Netherlands Cancer Institute, Amsterdam )

Comment on progression free survival in lung cancer patients and the GALAXY-1...

Dr Marjorie G. Zauderer - Memorial Sloan-Kettering Cancer Center, New York, USA

Comment on progression free survival in lung cancer patients and the GALAXY-1 trial ( Dr Marjorie G. Zauderer - Memorial Sloan-Kettering Cancer Center, New York, USA )

Paclitaxel dosing equally effective in preventing breast cancer progression

Dr Andrew Seidman - Memorial Sloan-Kettering Cancer Center, New York, USA

Paclitaxel dosing equally effective in preventing breast cancer progression ( Dr Andrew Seidman - Memorial Sloan-Kettering Cancer Center, New York, USA )

Paclitaxel chemotherapy schedules equally effective for early-stage breast...

Dr G. Thomas Budd - Cleveland Clinic, Cleveland, USA

Paclitaxel chemotherapy schedules equally effective for early-stage breast cancer ( Dr G. Thomas Budd - Cleveland Clinic, Cleveland, USA )

Ganetespib inhibits Hsp90 with docetaxel for advanced lung cancer

Dr Suresh S. Ramalingam - Emory University, Atlanta, USA

Ganetespib inhibits Hsp90 with docetaxel for advanced lung cancer ( Dr Suresh S. Ramalingam - Emory University, Atlanta, USA )

Nivolumab with peptide vaccine in patients naive to or that failed ipilimumab

Dr Jeffrey Weber - Moffitt Cancer Center, Tampa, USA

Nivolumab with peptide vaccine in patients naive to or that failed ipilimumab ( Dr Jeffrey Weber - Moffitt Cancer Center, Tampa, USA )

Nivolumab blocking PD1 in lung cancer and melanoma

Dr Suzanne Topalian - Johns Hopkins Medical Center, Baltimore, USA

Nivolumab blocking PD1 in lung cancer and melanoma ( Dr Suzanne Topalian - Johns Hopkins Medical Center, Baltimore, USA )

Nintedanib in combination with standard second line therapy in lung cancer

Dr Martin Reck - Hospital Grosshansdorf, Wohrendamm, Germany

Nintedanib in combination with standard second line therapy in lung cancer ( Dr Martin Reck - Hospital Grosshansdorf, Wohrendamm, Germany )

More from ecancer